In this video, High school students and educators from Lycée de la Vallée de Chevreuse in France share their perspectives on the Amgen Biotech Experience (ABE). Created by the Amgen Foundation, ABE is an innovative science education program that provides students with hands-on lab curriculum and teachers with the necessary tools to teach biotechnology in their classrooms.
In the last month, Maia Binding and her team have worked with some 30 teachers across the San Francisco Bay area to arm them with new tools and knowledge to share with their students this fall. The teachers come from schools in a variety of districts with varying demographics – many of which serve lower income populations. At these schools, students of all backgrounds have the opportunity for hands-on biotech, thanks to the Amgen Biotech Experience (ABE).
In this video, Amgen Scholars alumni tell their #BigImpactinBio stories, focusing on the importance of community building in science. Rachel Lucero (ASP 2014, University of California, San Diego) is a STEM teacher at the Dunbar School in Washington, D.C.; Marta Andrés Terré, Ph.D.
The core of the Amgen Biotech Experience (ABE) is a unique partnership between scientists and teachers. Amgen scientists contribute their expertise in cutting-edge research and desire to empower students in STEM, while teachers contribute their expertise in how to interest and motivate students and their desire to connect STEM to the real-world.
School is out for summer – or almost – for most high school students globally. But for some teachers, the learning is going to continue. Around the world, Amgen Biotech Experience (ABE) sites are gearing up for their professional development institutes, or PDIs. These multi-day workshops train high school teachers in the ABE curriculum, directly giving them experience with the hands-on biotech labs they’ll run in their classrooms when school resumes in the fall.
From an early age, Suzanne Rohrback had a unique insight into the need for science to bridge gaps in medical care. Her big brother is autistic and growing up, Rohrback remembers thinking there were no good options for him – unmedicated, he could be unpredictably violent and medicated, he would be zombie-like. “But we don’t understand enough about what goes wrong in this condition to have created a better solution,” she says.
In Hong Kong and much of the broader East Asia area, the educational system is highly focused on exams. Teachers have their hands full just trying to prepare their students for the intense testing that occurs. Lab time is often reserved only for after school extracurricular activities. But some teachers are still pushing themselves and their students even further, bringing real-world biotech into their labs.
The word “creativity” may not be traditionally associated with scientific research, but for Elisa D’Arcangelo, it sums up some of the aspects she most values about being a biomedical engineer. As a tissue engineer, she must come up with creative solutions for growing tissue in the lab that can help shape new therapies for cancer and other diseases.
As one of the world’s leading biotechnology companies, Amgen’s greatest contribution to society comes from discovering and developing innovative medicines to treat patients suffering from serious illnesses, such as cardiovascular disease and cancer. In undertaking this important work, Amgen makes a positive contribution in numerous other areas—which we share in our 2017 Responsibility Highlights Report.